Miller Industries, Inc. (MLR)
NYSE: MLR · Real-Time Price · USD
43.50
+1.40 (3.33%)
Aug 13, 2025, 4:00 PM - Market closed
ASLAN Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Revenue | 975.86 | 1,258 | 1,153 | 848.46 | 717.48 | 651.29 | Upgrade |
Revenue Growth (YoY) | -24.48% | 9.03% | 35.94% | 18.26% | 10.16% | -20.40% | Upgrade |
Cost of Revenue | 831.85 | 1,087 | 1,002 | 766.04 | 647.62 | 572.93 | Upgrade |
Gross Profit | 144.01 | 170.81 | 151.85 | 82.42 | 69.85 | 78.36 | Upgrade |
Selling, General & Admin | 88.67 | 86.32 | 73.09 | 52.83 | 46.23 | 39.71 | Upgrade |
Operating Expenses | 88.67 | 86.32 | 73.09 | 52.83 | 46.23 | 39.71 | Upgrade |
Operating Income | 55.34 | 84.48 | 78.77 | 29.59 | 23.62 | 38.64 | Upgrade |
Interest Expense | -6.92 | -9.83 | -8.37 | -3.38 | -1.36 | -1.22 | Upgrade |
Interest & Investment Income | 5.9 | 5.9 | 2.4 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.3 | -0.6 | 0.8 | - | - | 0.69 | Upgrade |
Other Non Operating Income (Expenses) | 0.07 | 0.3 | -0.06 | -0.53 | -0.54 | - | Upgrade |
EBT Excluding Unusual Items | 54.68 | 80.26 | 73.53 | 25.68 | 21.73 | 38.11 | Upgrade |
Gain (Loss) on Sale of Assets | -0.13 | -0.13 | 0.25 | 0.05 | 0.04 | -0.02 | Upgrade |
Pretax Income | 54.56 | 80.13 | 73.78 | 25.73 | 21.77 | 38.1 | Upgrade |
Income Tax Expense | 12.08 | 16.64 | 15.49 | 5.39 | 5.51 | 8.27 | Upgrade |
Earnings From Continuing Operations | 42.48 | 63.49 | 58.29 | 20.35 | 16.26 | 29.83 | Upgrade |
Net Income | 42.48 | 63.49 | 58.29 | 20.35 | 16.26 | 29.83 | Upgrade |
Net Income to Common | 42.48 | 63.49 | 58.29 | 20.35 | 16.26 | 29.83 | Upgrade |
Net Income Growth | -40.75% | 8.93% | 186.50% | 25.17% | -45.51% | -23.73% | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | 0.93% | 0.82% | 0.79% | 0.05% | 0.05% | 0.04% | Upgrade |
EPS (Basic) | 3.71 | 5.55 | 5.10 | 1.78 | 1.42 | 2.62 | Upgrade |
EPS (Diluted) | 3.64 | 5.47 | 5.07 | 1.78 | 1.42 | 2.62 | Upgrade |
EPS Growth | -41.58% | 7.89% | 184.83% | 25.35% | -45.71% | -23.76% | Upgrade |
Free Cash Flow | 34.17 | 1.52 | -1.13 | -48.09 | 6.12 | 43.21 | Upgrade |
Free Cash Flow Per Share | 2.94 | 0.13 | -0.10 | -4.21 | 0.54 | 3.79 | Upgrade |
Dividend Per Share | 0.780 | 0.760 | 0.720 | 0.720 | 0.720 | 0.720 | Upgrade |
Dividend Growth | 5.41% | 5.56% | - | - | - | - | Upgrade |
Gross Margin | 14.76% | 13.58% | 13.17% | 9.71% | 9.74% | 12.03% | Upgrade |
Operating Margin | 5.67% | 6.72% | 6.83% | 3.49% | 3.29% | 5.93% | Upgrade |
Profit Margin | 4.35% | 5.05% | 5.05% | 2.40% | 2.27% | 4.58% | Upgrade |
Free Cash Flow Margin | 3.50% | 0.12% | -0.10% | -5.67% | 0.85% | 6.63% | Upgrade |
EBITDA | 69.82 | 98.55 | 92.01 | 41.35 | 34.66 | 48.24 | Upgrade |
EBITDA Margin | 7.16% | 7.84% | 7.98% | 4.87% | 4.83% | 7.41% | Upgrade |
D&A For EBITDA | 14.48 | 14.07 | 13.24 | 11.76 | 11.04 | 9.6 | Upgrade |
EBIT | 55.34 | 84.48 | 78.77 | 29.59 | 23.62 | 38.64 | Upgrade |
EBIT Margin | 5.67% | 6.72% | 6.83% | 3.49% | 3.29% | 5.93% | Upgrade |
Effective Tax Rate | 22.13% | 20.76% | 21.00% | 20.93% | 25.32% | 21.70% | Upgrade |
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.